Paradigm Capital Management Inc. NY boosted its stake in Helen of Troy Limited (NASDAQ:HELE – Free Report) by 64.3% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 927,100 shares of the company’s stock after acquiring an additional 362,900 shares during the quarter. Paradigm Capital Management Inc. NY owned 3.99% of Helen of Troy worth $13,369,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Invenomic Capital Management LP lifted its holdings in Helen of Troy by 6.9% during the fourth quarter. Invenomic Capital Management LP now owns 593,310 shares of the company’s stock valued at $12,608,000 after purchasing an additional 38,325 shares in the last quarter. RWWM Inc. grew its position in shares of Helen of Troy by 85.7% in the first quarter. RWWM Inc. now owns 1,173,829 shares of the company’s stock valued at $16,927,000 after purchasing an additional 541,689 shares during the period. Aster Capital Management DIFC Ltd purchased a new stake in shares of Helen of Troy during the fourth quarter worth about $504,000. Prescott Group Capital Management L.L.C. purchased a new stake in shares of Helen of Troy during the fourth quarter worth about $2,344,000. Finally, UBS Group AG raised its position in shares of Helen of Troy by 386.0% during the 4th quarter. UBS Group AG now owns 616,992 shares of the company’s stock worth $13,111,000 after purchasing an additional 490,031 shares during the last quarter.
Helen of Troy Stock Up 6.1%
HELE stock opened at $28.47 on Friday. The company has a market cap of $663.12 million, a price-to-earnings ratio of -1.58 and a beta of 1.31. The company has a current ratio of 1.78, a quick ratio of 0.81 and a debt-to-equity ratio of 0.82. Helen of Troy Limited has a 12 month low of $13.85 and a 12 month high of $30.68. The firm has a 50-day moving average of $27.05 and a two-hundred day moving average of $21.45.
More Helen of Troy News
Here are the key news stories impacting Helen of Troy this week:
- Positive Sentiment: A recent valuation-focused article highlighted Helen of Troy as potentially still undervalued even after a sharp rally, suggesting some investors may see room for further upside. Is It Too Late to Buy Helen Of Troy Ltd (HELE) After 3.3% Rally? GF Value Says Undervalued
- Neutral Sentiment: Several entertainment-related articles mention “Helen of Troy” in connection with Lupita Nyong’o and Christopher Nolan’s The Odyssey, but these are unrelated to the company and should not affect fundamentals. Teacher schools white people who have a problem with Lupita Nyong’o as Helen of Troy
- Neutral Sentiment: Additional media references to “Helen of Troy” in entertainment coverage are likewise not business updates for the consumer-products company. I’m a Black Greek Woman. What Lupita Nyong’o’s Casting as Helen of Troy in ‘The Odyssey’ Meant to Me
- Negative Sentiment: Multiple law firms announced or reminded investors about a class-action lawsuit against Helen of Troy Limited, alleging securities-law violations and investor harm for purchases made between April 24, 2024 and October 8, 2025. This legal overhang can weigh on sentiment as investors assess potential costs and reputational damage. Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm
- Negative Sentiment: Another investor alert repeated the same class-action claims and deadline reminders, reinforcing concerns about litigation risk for HELE. HELE Investors are Reminded of the Pending Lead Plaintiff Deadline on August 3, 2026; Contact Robbins LLP for Information About Recovering Your Losses
- Negative Sentiment: A third legal notice from Pomerantz LLP also flagged the lawsuit and upcoming deadlines, adding to the steady stream of negative headline risk around the stock. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Helen of Troy Limited of Class Action Lawsuit and Upcoming Deadlines – HELE
Analyst Ratings Changes
A number of research analysts recently weighed in on the stock. Zacks Research lowered shares of Helen of Troy from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Wall Street Zen upgraded Helen of Troy from a “hold” rating to a “strong-buy” rating in a research note on Sunday, July 12th. Canaccord Genuity Group increased their target price on Helen of Troy from $23.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, July 9th. Weiss Ratings cut Helen of Troy from a “sell (d)” rating to a “sell (d-)” rating in a report on Tuesday. Finally, UBS Group raised their target price on Helen of Troy from $25.00 to $28.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $26.50.
Read Our Latest Stock Analysis on Helen of Troy
Helen of Troy Company Profile
Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.
The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.
Further Reading
- Five stocks we like better than Helen of Troy
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding HELE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helen of Troy Limited (NASDAQ:HELE – Free Report).
Receive News & Ratings for Helen of Troy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helen of Troy and related companies with MarketBeat.com's FREE daily email newsletter.
